The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno, J.
Right arrow Articles by Hammerling, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreno, J.
Right arrow Articles by Hammerling, G. J.

The Journal of Immunology, Vol 147, Issue 10 3306-3313, Copyright © 1991 by American Association of Immunologists


ARTICLES

Processing of an endogenous protein can generate MHC class II- restricted T cell determinants distinct from those derived from exogenous antigen

J Moreno, DA Vignali, F Nadimi, S Fuchs, L Adorini and GJ Hammerling
Institute for Immunology and Genetics, German Cancer Research Center (DKFZ), Heidelberg.

Class II MHC molecules on the surface of an APC present immunogenic peptides derived mainly from exogenous proteins to CD4+ T cells. During its transport to the cell surface, class II molecules intersect the endocytic pathway where they acquire peptides derived from endocytosed proteins. However, class II-restricted presentation of endogenously derived peptides can also occur. The current studies were undertaken to examine the ability of different types of APC to generate and present four different T cell determinants derived from an endogenous, nonsecreted, truncated form of hen-egg white lysozyme (HEL[1-80]-Kk). This was compared with the ability of these APC to generate the same determinants from exogenous HEL. All the peptides derived from endogenous HEL[1-80]-Kk tested, were presented by B cells to HEL- specific T cell hybridomas with an efficiency similar to presentation of the same determinants from exogenous HEL. In contrast, an I-Ak- bearing rat fibroblast was unable to generate the HEL peptide 25-43 from exogenous HEL, but could efficiently produce it from endogenous HEL[1-80]-Kk. The results indicate first, that peptides derived from an endogenous Ag can be presented by MHC class II molecules with an efficiency comparable to that of the presentation of the exogenous Ag. Second, that Ag-presenting B cells can generate the same repertoire of antigenic peptides from endogenous Ag as those generated from the exogenous protein. And third, that in contrast to B cells, certain "nonprofessional" APC can generate, from an endogenous protein, T cell determinants distinct from those generated after endocytosis of the exogenous protein. These results suggest that processing of exogenous and endogenous Ag by different APC take place in different intracellular compartments.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. S. Neelapu, S. Baskar, B. L. Gause, C. B. Kobrin, T. M. Watson, A. R. Frye, R. Pennington, L. Harvey, E. S. Jaffe, R. J. Robb, et al.
Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen
Clin. Cancer Res., December 15, 2004; 10(24): 8309 - 8317.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. N. Pichurin, G. D. Chazenbalk, H. Aliesky, O. Pichurina, B. Rapoport, and S. M. McLachlan
"Hijacking" the Thyrotropin Receptor: A Chimeric Receptor-Lysosome Associated Membrane Protein Enhances Deoxyribonucleic Acid Vaccination and Induces Graves' Hyperthyroidism
Endocrinology, December 1, 2004; 145(12): 5504 - 5514.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. T. A. Marques Jr., P. Chikhlikar, L. B. de Arruda, I. C. Leao, Y. Lu, J. Wong, J.-S. Chen, B. Byrne, and J. T. August
HIV-1 p55Gag Encoded in the Lysosome-associated Membrane Protein-1 as a DNA Plasmid Vaccine Chimera Is Highly Expressed, Traffics to the Major Histocompatibility Class II Compartment, and Elicits Enhanced Immune Responses
J. Biol. Chem., September 26, 2003; 278(39): 37926 - 37936.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Rodriguez, S. Harkins, J. M. Redwine, J. M. de Pereda, and J. L. Whitton
CD4+ T Cells Induced by a DNA Vaccine: Immunological Consequences of Epitope-Specific Lysosomal Targeting
J. Virol., November 1, 2001; 75(21): 10421 - 10430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. T. Carson, D. D. Desai, K. M. Vignali, and D. A. A. Vignali2
Cutting Edge: Immunoregulation of Th Cells by Naturally Processed Peptide Antagonists
J. Immunol., January 1, 1999; 162(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. M. Gross, T. Forsthuber, M. Tary-Lehmann, C. Etling, K. Ito, Z. A. Nagy, J. A. Field, A. C. Steere, and B. T. Huber
Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
Science, July 31, 1998; 281(5377): 703 - 706.
[Abstract] [Full Text]


Home page
ScienceHome page
H Bodmer, S Viville, C Benoist, and D Mathis
Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain
Science, March 4, 1994; 263(5151): 1284 - 1286.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.